Similarly, the downregulation of Per2 was observed in samples derived from The Cancer Genome Atlas (TCGA) database (Chen et al., 2013), and Per2 deregulation in tumors was found to be linked with increased mortality in the cohort of patients with glioma (Chang and Lai, 2019). Here, PER2 is linked to central nervous system cancer.